En la esclerosis sistémica, el esófago se afecta en un 90%, seguido de los tramos anorrectal (%), gástrico ( 70%), colon (%) e intestino delgado. La esclerodermia es un relativamente infrecuente enfermedad reumática autoinmunitaria que afecta la piel y otros órganos del cuerpo. La esclerosis sistémica es una enfermedad autoinmune del tejido conectivo, que se caracteriza por un depósito excesivo de tejido colágeno y otros.

Author: Molabar Tasho
Country: Gabon
Language: English (Spanish)
Genre: Spiritual
Published (Last): 14 November 2008
Pages: 478
PDF File Size: 14.96 Mb
ePub File Size: 7.3 Mb
ISBN: 745-4-58332-848-4
Downloads: 16322
Price: Free* [*Free Regsitration Required]
Uploader: Samugar

Br J Dermatol,pp. A study of fifty-eight autopsy cases and fifty-eight matched controls. Arch Intern Med,pp. Increased whole blood platelet aggregation in patients with Raynaud’s phenomenon with or without systemic sclerosis.

Ann Rheum Dis, 62pp. Scleroderma patients nailfold videocapillarooscopic patterns associated with disease subset and disease severity. The influence of different sistemiva drugs on the peripheral circulation in Raynaud phenomenon and in hypertension. Rheumatology, 39 esclerosiis, pp. Joint Bone Spine, 72pp. Cardiac and skeletal muscle disease in systemic sclerosis scleroderma: Disturbed right ventricular diastolic function in patients with systemic sclerosis: Rheumatology, 44pp.


Pathologic observations in systemic sclerosis scleroderma.

Recombinant human relaxin in the treatment of scleroderma. Circulation, 53pp. Semin Arthritis Rheum, 33pp. J Rheumatol, 20pp.

Tratamiento de la esclerosis sistémica | Reumatología Clínica

Rheum Dis Clin N Am, 31pp. Neuropathic pain in Systemic Sclerosis patients: Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis.

Reumatismo, 54pp. Z Rheumatol, 63pp. Clin Pharmacol Ther, 40pp. Ann Rheum Dis, 62pp.

There was a problem providing the content you requested

In colonoscopy, multiple telangiectases were visualized from the anus to the cecum Fig. N Eng J Med,pp. Effect of ketanserin on Raynaud’s phenomenon in progressive systemic sclerosis: Microvascular involvement in Systemic Sclerosis: Alteration of arterial escleroais in systemic sclerosis. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders.

Assessment of microvascular changes in Raynaud’s phenomenon and connective tissue disease using colour Doppler ultrasound. J Rheumatol, 32pp. JDDG, 5pp. J Rheumatol, 29escclerosis. Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud’s phenomenon.


Ann Ital Med Int, 16pp. Giusti De Marle, A. Interferongamma in the treatment of systemic sclerosis: Ann Rheum Dis, 55pp.

Rheum Dis Clin North Am, 22pp. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Preliminary thermographic evaluation of new nitroglycerine tape on the peripheral circulatory disturbance in systemic sclerosis. Important complications of fibrosis escledosis left ventricular hypertrophy, as well as systolic and diastolic dysfunction of both ventricles.

Clin Hemorheol Microcirc, 31pp.